Skip to content
OpenCapital
Get started

PMV Pharmaceuticals PMVP Q1 2026 earnings

Reported May 12, 2026 · Before market open

Diluted EPS-$0.34Beat by $0.07
EPS estimate-$0.41

Next report

Aug 6, 2026 (In 3 weeks)
EPS estimate-$0.38

Versus estimates

Diluted EPS

Q1 2026-$0.34Beat by $0.07
Q4 2025-$0.34Beat by $0.06Q3 2025-$0.40In lineQ2 2025-$0.41Miss by $0.02Q1 2025-$0.34Beat by $0.03Q4 2024-$0.45Miss by $0.07

Ask the moment PMV Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did PMV Pharmaceuticals report Q1 2026 earnings?
PMV Pharmaceuticals (PMVP) reported Q1 2026 earnings on May 12, 2026 before market open.
What were PMV Pharmaceuticals's Q1 2026 revenue and EPS?
PMV Pharmaceuticals reported diluted EPS of $-0.34 for Q1 2026.
Did PMV Pharmaceuticals beat estimates in Q1 2026?
EPS beat the consensus estimate of $-0.41 by $0.07.
How did PMV Pharmaceuticals's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS grew 0.0% from $-0.34.
Where can I find PMV Pharmaceuticals's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-218225) and the 10-Q periodic report (0001193125-26-218227) directly on SEC EDGAR. The filing index links above go to sec.gov.